These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31934268)

  • 1. Resumption of Autophagy by Ubisol-Q
    Vegh C; Pupulin S; Wear D; Culmone L; Huggard R; Ma D; Pandey S
    Oxid Med Cell Longev; 2019; 2019():7404815. PubMed ID: 31934268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.
    Muthukumaran K; Kanwar A; Vegh C; Marginean A; Elliott A; Guilbeault N; Badour A; Sikorska M; Cohen J; Pandey S
    J Alzheimers Dis; 2018; 61(1):221-236. PubMed ID: 29154270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of stress induced premature senescence in presenilin-1 mutated cells with water soluble Coenzyme Q10.
    Ma D; Stokes K; Mahngar K; Domazet-Damjanov D; Sikorska M; Pandey S
    Mitochondrion; 2014 Jul; 17():106-15. PubMed ID: 25034304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson's disease.
    Muthukumaran K; Leahy S; Harrison K; Sikorska M; Sandhu JK; Cohen J; Keshan C; Lopatin D; Miller H; Borowy-Borowski H; Lanthier P; Weinstock S; Pandey S
    BMC Neurosci; 2014 Jan; 15():21. PubMed ID: 24483602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic susceptibility model of Parkinson's disease resulting from exposure of DJ-1 deficient mice to MPTP: evaluation of neuroprotection by Ubisol-Q10.
    Muthukumaran K; Smith J; Jasra H; Sikorska M; Sandhu JK; Cohen J; Lopatin D; Pandey S
    J Parkinsons Dis; 2014; 4(3):523-530. PubMed ID: 25061060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.
    Sikorska M; Lanthier P; Miller H; Beyers M; Sodja C; Zurakowski B; Gangaraju S; Pandey S; Sandhu JK
    Neurobiol Aging; 2014 Oct; 35(10):2329-46. PubMed ID: 24775711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubisol-Q
    Wear D; Vegh C; Sandhu JK; Sikorska M; Cohen J; Pandey S
    Antioxidants (Basel); 2021 May; 10(5):. PubMed ID: 34064983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation.
    Yang X; Yang Y; Li G; Wang J; Yang ES
    J Mol Neurosci; 2008 Feb; 34(2):165-71. PubMed ID: 18181031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubisol-Q10 Prevents Glutamate-Induced Cell Death by Blocking Mitochondrial Fragmentation and Permeability Transition Pore Opening.
    Kumari S; Mehta SL; Milledge GZ; Huang X; Li H; Li PA
    Int J Biol Sci; 2016; 12(6):688-700. PubMed ID: 27194946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Ubisol-Q
    Vegh C; Wear D; Okaj I; Huggard R; Culmone L; Eren S; Cohen J; Rishi AK; Pandey S
    Antioxidants (Basel); 2021 Apr; 10(4):. PubMed ID: 33917328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic cleavage of Beclin 1 exacerbates neurodegeneration.
    Bieri G; Lucin KM; O'Brien CE; Zhang H; Villeda SA; Wyss-Coray T
    Mol Neurodegener; 2018 Dec; 13(1):68. PubMed ID: 30594228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease.
    Sui X; Ren X; Huang P; Li S; Ma Q; Ying M; Ni J; Liu J; Yang X
    J Alzheimers Dis; 2014; 40(3):575-86. PubMed ID: 24496070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-asarone improves learning and memory and reduces Acetyl Cholinesterase and Beta-amyloid 42 levels in APP/PS1 transgenic mice by regulating Beclin-1-dependent autophagy.
    Deng M; Huang L; Ning B; Wang N; Zhang Q; Zhu C; Fang Y
    Brain Res; 2016 Dec; 1652():188-194. PubMed ID: 27737765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Role of JNK1 in the Hippocampus in an Experimental Model of Familial Alzheimer's Disease.
    Petrov D; Luque M; Pedrós I; Ettcheto M; Abad S; Pallàs M; Verdaguer E; Auladell C; Folch J; Camins A
    Mol Neurobiol; 2016 Nov; 53(9):6183-6193. PubMed ID: 26558630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bird's-Eye View of the Multiple Biochemical Mechanisms that Propel Pathology of Alzheimer's Disease: Recent Advances and Mechanistic Perspectives on How to Halt the Disease Progression Targeting Multiple Pathways.
    Vegh C; Stokes K; Ma D; Wear D; Cohen J; Ray SD; Pandey S
    J Alzheimers Dis; 2019; 69(3):631-649. PubMed ID: 31127770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dickkopf 3 (Dkk3) Improves Amyloid-β Pathology, Cognitive Dysfunction, and Cerebral Glucose Metabolism in a Transgenic Mouse Model of Alzheimer's Disease.
    Zhang L; Sun C; Jin Y; Gao K; Shi X; Qiu W; Ma C; Zhang L
    J Alzheimers Dis; 2017; 60(2):733-746. PubMed ID: 28922151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of the β-secretase inhibitor GRL-8234 in 5XFAD Alzheimer's transgenic mice lessen during disease progression.
    Devi L; Tang J; Ohno M
    Curr Alzheimer Res; 2015; 12(1):13-21. PubMed ID: 25523425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice.
    Cheng D; Spiro AS; Jenner AM; Garner B; Karl T
    J Alzheimers Dis; 2014; 42(4):1383-96. PubMed ID: 25024347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.